Publication: Targeted gene disruption of the 14-alpha sterol demethylase (cyp51A) in Aspergillus fumigatus and its role in azole drug susceptibility
| dc.contributor.author | Mellado, Emilia | |
| dc.contributor.author | Garcia-Effron, Guillermo | |
| dc.contributor.author | Buitrago, Maria Jose | |
| dc.contributor.author | Alcazar-Fuoli, Laura | |
| dc.contributor.author | Cuenca-Estrella, Manuel | |
| dc.contributor.author | Rodriguez-Tudela, Juan Luis | |
| dc.contributor.funder | Instituto de Salud Carlos III | |
| dc.contributor.funder | Ministerio de Ciencia y Tecnología (España) | |
| dc.date.accessioned | 2019-05-31T10:32:26Z | |
| dc.date.available | 2019-05-31T10:32:26Z | |
| dc.date.issued | 2005-06 | |
| dc.description.abstract | The role of Aspergillus fumigatus 14alpha-sterol demethylase (Cyp51A) in azole drug susceptibility was assessed. Targeted disruption of cyp51A in azole-susceptible and -resistant strains decreased MICs from 2- to 40-fold. The cyp51A mutants were morphologically indistinguishable from the wild-type strain, retaining the ability to cause pulmonary disease in neutropenic mice. | es_ES |
| dc.description.peerreviewed | Sí | es_ES |
| dc.description.sponsorship | This work was supported in part by grants MPY1120/03 from Instituto de Salud Carlos III and SAF2002-02089 from the Ministry of Science and Technology. E. Mellado held a Ramo´n y Cajal contract from the Ministry of Science and Technology. L. Alcazar-Fuoli has a predoctoral fellowship from the Instituto de Salud Carlos III. | es_ES |
| dc.format.number | 6 | es_ES |
| dc.format.page | 2536-8 | es_ES |
| dc.format.volume | 49 | es_ES |
| dc.identifier.citation | Antimicrob Agents Chemother. 2005;49(6):2536-8. | es_ES |
| dc.identifier.doi | 10.1128/AAC.49.6.2536-2538 | es_ES |
| dc.identifier.issn | 0066-4804 | es_ES |
| dc.identifier.journal | Antimicrobial agents and chemotherapy | es_ES |
| dc.identifier.pubmedID | 15917566 | es_ES |
| dc.identifier.uri | http://hdl.handle.net/20.500.12105/7702 | |
| dc.language.iso | eng | es_ES |
| dc.publisher | American Society for Microbiology (ASM) | es_ES |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/MPY1120/03 | es_ES |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/SAF2002-02089 | es_ES |
| dc.relation.publisherversion | https://doi.org/10.1128/AAC.49.6.2536-2538.2005 | es_ES |
| dc.repisalud.centro | ISCIII::Centro Nacional de Microbiología | es_ES |
| dc.repisalud.institucion | ISCIII | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.rights.license | Atribución-NoComercial-CompartirIgual 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ | * |
| dc.title | Targeted gene disruption of the 14-alpha sterol demethylase (cyp51A) in Aspergillus fumigatus and its role in azole drug susceptibility | es_ES |
| dc.type | journal article | es_ES |
| dc.type.hasVersion | AM | es_ES |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | f189cece-f159-4ab4-b47d-ec72ca9af3e2 | |
| relation.isAuthorOfPublication | 4b33804a-2b9b-4d98-9d80-c0525ff1b3b9 | |
| relation.isAuthorOfPublication | b9452675-1d4d-4da5-9f03-f9b1bbc67353 | |
| relation.isAuthorOfPublication | edbfddd9-077c-48b7-aa3a-9e3414469c6e | |
| relation.isAuthorOfPublication | 97aa0ff7-7128-4c03-a014-1200e997c819 | |
| relation.isAuthorOfPublication | 0f6c083c-c0af-4b54-b7ca-ae867ce908b3 | |
| relation.isAuthorOfPublication.latestForDiscovery | f189cece-f159-4ab4-b47d-ec72ca9af3e2 |
Files
Original bundle
1 - 4 of 4
Loading...
- Name:
- TargetedGeneDisruption14_2005.pdf
- Size:
- 562.92 KB
- Format:
- Adobe Portable Document Format
Loading...
- Name:
- Figure1_TargetedGeneDisruption14.pdf
- Size:
- 43.56 KB
- Format:
- Adobe Portable Document Format
Loading...
- Name:
- Figure2_TargetedGeneDisruption14.pdf
- Size:
- 17.58 KB
- Format:
- Adobe Portable Document Format
Loading...
- Name:
- Tabla1_TargetedGeneDisruption14.pdf
- Size:
- 99.65 KB
- Format:
- Adobe Portable Document Format


